Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -3.56%129.41M | -26.71%264.77M | -26.52%134.19M | 14.64%361.26M | 22.04%182.63M | 47.49%315.14M | 32.41%149.65M | -23.42%213.67M | -9.92%113.02M | -20.72%279.02M |
| Operating income | -3.56%129.41M | -26.71%264.77M | -26.52%134.19M | 14.64%361.26M | 22.04%182.63M | 47.49%315.14M | 32.41%149.65M | -23.42%213.67M | -9.92%113.02M | -20.72%279.02M |
| Cost of sales | 2.27%-120.02M | 25.52%-245.79M | 25.84%-122.82M | -17.55%-330.01M | -29.48%-165.62M | -55.00%-280.74M | -31.82%-127.91M | 33.46%-181.13M | 27.21%-97.03M | 19.19%-272.19M |
| Operating expenses | 2.27%-120.02M | 25.52%-245.79M | 25.84%-122.82M | -17.55%-330.01M | -29.48%-165.62M | -55.00%-280.74M | -31.82%-127.91M | 33.46%-181.13M | 27.21%-97.03M | 19.19%-272.19M |
| Gross profit | -17.45%9.39M | -39.25%18.98M | -33.11%11.38M | -9.15%31.25M | -21.74%17.01M | 5.71%34.4M | 35.96%21.74M | 376.44%32.54M | 303.73%15.99M | -54.83%6.83M |
| Administrative expenses | 27.17%-8.35M | 4.99%-22.68M | -6.41%-11.47M | 3.99%-23.87M | 8.82%-10.77M | 4.05%-24.87M | 2.60%-11.82M | -2.06%-25.92M | 1.75%-12.13M | 4.68%-25.39M |
| Impairment and provision | -108.88%-77K | -330.95%-4.09M | --867K | ---950K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -108.88%-77K | -330.95%-4.09M | --867K | ---950K | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | -71.83%869K | 13.62%3.85M | 85.06%3.09M | -38.04%3.38M | 189.38%1.67M | -18.43%5.46M | -175.14%-1.87M | 37.33%6.7M | -50.58%2.48M | -63.07%4.88M |
| Operating profit | -52.53%1.84M | -140.27%-3.95M | -51.09%3.87M | -34.57%9.81M | -1.87%7.9M | 12.57%14.99M | 27.09%8.06M | 197.30%13.32M | 141.77%6.34M | -914.22%-13.69M |
| Financing cost | 52.78%-1.66M | -3.26%-5.7M | -29.65%-3.52M | -32.90%-5.52M | -53.56%-2.72M | -95.53%-4.16M | -86.50%-1.77M | -169.67%-2.13M | -203.85%-948K | -125.14%-788K |
| Earning before tax | -50.00%173K | -325.20%-9.65M | -93.33%346K | -60.45%4.29M | -17.46%5.19M | -3.18%10.84M | 16.64%6.29M | 177.32%11.19M | 134.81%5.39M | -1,187.53%-14.48M |
| After-tax profit from continuing operations | -50.00%173K | -325.20%-9.65M | -93.33%346K | -60.45%4.29M | -17.46%5.19M | -3.18%10.84M | 16.64%6.29M | 177.32%11.19M | 134.81%5.39M | -1,187.53%-14.48M |
| Earning after tax | -50.00%173K | -325.20%-9.65M | -93.33%346K | -60.45%4.29M | -17.46%5.19M | -3.18%10.84M | 16.64%6.29M | 177.32%11.19M | 134.81%5.39M | -1,187.53%-14.48M |
| Profit attributable to shareholders | -50.00%173K | -325.20%-9.65M | -93.33%346K | -60.45%4.29M | -17.46%5.19M | -3.18%10.84M | 16.64%6.29M | 177.32%11.19M | 134.81%5.39M | -1,187.53%-14.48M |
| Basic earnings per share | -40.00%0.0003 | -323.81%-0.0141 | -93.42%0.0005 | -60.13%0.0063 | -17.39%0.0076 | -3.07%0.0158 | 16.46%0.0092 | 177.25%0.0163 | 134.96%0.0079 | -1,210.53%-0.0211 |
| Diluted earnings per share | -40.00%0.0003 | -323.81%-0.0141 | -93.42%0.0005 | -60.13%0.0063 | -17.39%0.0076 | -3.07%0.0158 | 16.46%0.0092 | 177.25%0.0163 | 134.96%0.0079 | -1,210.53%-0.0211 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Changqing (Hong Kong) Accounting Firm Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. | -- | Kaiyuan Shun Tak Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.